Paul Williams

Summary

Affiliation: PAREXEL International

Publications

  1. ncbi request reprint The cost-effectiveness of patient-applied treatments for anogenital warts
    Paul Williams
    PAREXEL MMS, Uxbridge, UK
    Int J STD AIDS 14:228-34. 2003
  2. ncbi request reprint Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine
    Paul Williams
    PAREXEL International, Uxbridge, Middlesex, United Kingdom
    Clin Ther 25:2903-19. 2003
  3. ncbi request reprint A comparison of the cost-effectiveness of almotriptan and sumatriptan in the treatment of acute migraine using a composite efficacy/tolerability end point
    Paul Williams
    PAREXEL International, The Quays, 101 105 Oxford Rd, Uxbridge, Middlesex, UB8 1LZ, UK
    J Manag Care Pharm 10:259-65. 2004
  4. ncbi request reprint Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)
    F Michael Cutrer
    Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Ther 26:1533-45. 2004
  5. ncbi request reprint Bacterial cell-to-cell communication: sorry, can't talk now - gone to lunch!
    Klaus Winzer
    Institute of Infections and Immunity, University of Nottingham, Queen s Medical Centre, NG7 2UH, Nottingham, United Kingdom
    Curr Opin Microbiol 5:216-22. 2002
  6. ncbi request reprint Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project
    David W Dodick
    Department of Neurology, Mayo Clinic Scottsdale, AZ 85259, USA
    Curr Pain Headache Rep 8:435-42. 2004
  7. ncbi request reprint Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine
    David W Dodick
    Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA
    CNS Drugs 21:73-82. 2007

Collaborators

Detail Information

Publications7

  1. ncbi request reprint The cost-effectiveness of patient-applied treatments for anogenital warts
    Paul Williams
    PAREXEL MMS, Uxbridge, UK
    Int J STD AIDS 14:228-34. 2003
    ..Sensitivity analyses showed the economic superiority of podophyllotoxin to be robust and statistically very significant...
  2. ncbi request reprint Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine
    Paul Williams
    PAREXEL International, Uxbridge, Middlesex, United Kingdom
    Clin Ther 25:2903-19. 2003
    ..Seven triptans, including almotriptan and rizatriptan, are recommended as first-line therapy for acute migraine...
  3. ncbi request reprint A comparison of the cost-effectiveness of almotriptan and sumatriptan in the treatment of acute migraine using a composite efficacy/tolerability end point
    Paul Williams
    PAREXEL International, The Quays, 101 105 Oxford Rd, Uxbridge, Middlesex, UB8 1LZ, UK
    J Manag Care Pharm 10:259-65. 2004
    ..To use a composite efficacy/tolerability end point to compare the cost-effectiveness, from the perspective of a U.S. health care payer, of almotriptan and sumatriptan in the treatment of an acute migraine attack...
  4. ncbi request reprint Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)
    F Michael Cutrer
    Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Ther 26:1533-45. 2004
    ..Physicians treating patients with migraine can now choose from among 7 triptans, which differ on a range of attributes that may be important for treatment selection...
  5. ncbi request reprint Bacterial cell-to-cell communication: sorry, can't talk now - gone to lunch!
    Klaus Winzer
    Institute of Infections and Immunity, University of Nottingham, Queen s Medical Centre, NG7 2UH, Nottingham, United Kingdom
    Curr Opin Microbiol 5:216-22. 2002
    ..This depends on rigorous chemical characterisation and demonstration that the molecule controls cellular responses beyond those required to metabolise or detoxify the signal...
  6. ncbi request reprint Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project
    David W Dodick
    Department of Neurology, Mayo Clinic Scottsdale, AZ 85259, USA
    Curr Pain Headache Rep 8:435-42. 2004
    ..Using a multiattribute decision model, we combined these data on the importance of treatment attributes with information on the relative performance of the oral triptans derived from a recent meta-analysis of controlled clinical trials...
  7. ncbi request reprint Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine
    David W Dodick
    Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, USA
    CNS Drugs 21:73-82. 2007
    ....